The Next Outbreak Looms on the Horizon: Measles and Potential Impacts on Transplant Recipients

Ayman Al Jurdi,Camille N. Kotton

DOI: https://doi.org/10.1097/tp.0000000000005083

2024-09-26

Transplantation

Abstract:Significant outbreaks of measles are occurring throughout the world, including the United States, the United Kingdom, India, and other areas with significant rates of organ transplantation, fed in part by vaccine reluctance and lower rates of childhood vaccination. 1 , 2 Measles is transmitted via airborne spread or respiratory droplets and is among the most contagious of pathogens with infection occurring in up to 90% of nonimmune close contacts 3 ; a single case of infection is estimated to cause 12–18 secondary cases in susceptible individuals 1 , 4 and may be even more contagious in susceptible immunocompromised populations. Measles typically presents with fever, maculopapular rash, conjunctivitis, cough, and coryza, although such symptoms may be muted in transplant recipients, who may present without a rash. 5 , 6 Serious manifestations of the disease include pneumonia due to measles virus or superimposed secondary infection and acute disseminated encephalomyelitis, a demyelinating disease of the central nervous system that develops in 1:1000 cases. 5 There is no effective antiviral treatment for measles and the management is supportive. 5 Beyond the acute mortality, long-term sequelae also contribute to morbidity and delayed mortality: disability related to permanent brain damage from acute encephalomyelitis; measles inclusion body encephalitis, which occurs typically in immunocompromised individuals 6–12 mo after infection; and subacute sclerosing panencephalitis, a fatal progressive neurodegenerative disease that occurs years later in roughly 1:10 000 of cases. 1 , 5 , 7 Rates and outcomes in immunocompromised patients are largely unstudied; as with so many other infections, they are likely at higher risk for severe outcomes. 6

immunology,surgery,transplantation